The association between area-level factors and mortality in severe mental illnesses: A systematic review.

Area-level factors Bipolar disorder Mortality Schizophrenia Severe mental illness Systematic review

Journal

Schizophrenia research
ISSN: 1573-2509
Titre abrégé: Schizophr Res
Pays: Netherlands
ID NLM: 8804207

Informations de publication

Date de publication:
Feb 2024
Historique:
received: 08 03 2022
revised: 06 07 2023
accepted: 10 12 2023
medline: 1 3 2024
pubmed: 21 12 2023
entrez: 20 12 2023
Statut: ppublish

Résumé

Premature mortality is a well-documented adverse outcome for people living with severe mental illnesses (SMI). Emerging evidence suggests that area-level factors play a role that are experienced disproportionately by this population. This review assesses the potential association between area-level factors and mortality in people with SMI. We searched Medline, EMBASE, PsychINFO, Social Policy and Practice, Web of Science and OpenGrey databases. Literature searches were conducted in May 2020 and updated in June 2023. Reference lists were hand-searched and authors of included studies contacted to identify additional studies and minimise publication biases. Narrative synthesis was used to appraise the included studies. The review protocol was registered on PROSPERO (CRD42019155447). Our searches identified 7 studies (8 papers), which were included in the review, and indicated evidence of an association between deprivation and mortality. One study suggested an association between mortality in SMI and urbanicity in low to middle income settings which was not observed in studies from high income settings. One study suggested a protective association of area-level ethnic density with mortality within urbanised settings. Consistent associations were reported between residence in areas of higher deprivation and increased risk of mortality in SMI. Two studies suggested an association between area-level ethnic density and urbanicity and mortality in SMI. Most studies were conducted across high income countries and therefore future research could benefit from similar investigations being conducted in low- and middle-income countries. These methods would inform health and social policies, including interventions to reduce premature mortality in SMI.

Sections du résumé

BACKGROUND BACKGROUND
Premature mortality is a well-documented adverse outcome for people living with severe mental illnesses (SMI). Emerging evidence suggests that area-level factors play a role that are experienced disproportionately by this population. This review assesses the potential association between area-level factors and mortality in people with SMI.
METHOD METHODS
We searched Medline, EMBASE, PsychINFO, Social Policy and Practice, Web of Science and OpenGrey databases. Literature searches were conducted in May 2020 and updated in June 2023. Reference lists were hand-searched and authors of included studies contacted to identify additional studies and minimise publication biases. Narrative synthesis was used to appraise the included studies. The review protocol was registered on PROSPERO (CRD42019155447).
RESULTS RESULTS
Our searches identified 7 studies (8 papers), which were included in the review, and indicated evidence of an association between deprivation and mortality. One study suggested an association between mortality in SMI and urbanicity in low to middle income settings which was not observed in studies from high income settings. One study suggested a protective association of area-level ethnic density with mortality within urbanised settings.
CONCLUSION CONCLUSIONS
Consistent associations were reported between residence in areas of higher deprivation and increased risk of mortality in SMI. Two studies suggested an association between area-level ethnic density and urbanicity and mortality in SMI. Most studies were conducted across high income countries and therefore future research could benefit from similar investigations being conducted in low- and middle-income countries. These methods would inform health and social policies, including interventions to reduce premature mortality in SMI.

Identifiants

pubmed: 38118264
pii: S0920-9964(23)00450-4
doi: 10.1016/j.schres.2023.12.012
pii:
doi:

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

95-104

Subventions

Organisme : Medical Research Council
ID : MR/K021494/1
Pays : United Kingdom

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Auteurs

D Laporte (D)

King's College London (Institute of Psychiatry, Psychology & Neurosciences), London, United Kingdom; NIHR Maudsley Biomedical Research Centre (BRC), South London and Maudsley NHS Foundation Trust, United Kingdom. Electronic address: dionne.s.laporte@kcl.ac.uk.

N Chilman (N)

King's College London (Institute of Psychiatry, Psychology & Neurosciences), London, United Kingdom; Economic and Social Research Council (ESRC), KCL Centre for Society and Mental Health, United Kingdom.

C Morgan (C)

King's College London (Institute of Psychiatry, Psychology & Neurosciences), London, United Kingdom; Economic and Social Research Council (ESRC), KCL Centre for Society and Mental Health, United Kingdom.

P Schofield (P)

School of Life Course and Population Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.

T Wykes (T)

King's College London (Institute of Psychiatry, Psychology & Neurosciences), London, United Kingdom; NIHR Maudsley Biomedical Research Centre (BRC), South London and Maudsley NHS Foundation Trust, United Kingdom.

J Das-Munshi (J)

King's College London (Institute of Psychiatry, Psychology & Neurosciences), London, United Kingdom; NIHR Maudsley Biomedical Research Centre (BRC), South London and Maudsley NHS Foundation Trust, United Kingdom; Economic and Social Research Council (ESRC), KCL Centre for Society and Mental Health, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH